OPKO Health Inc. Logo

OPKO Health Inc.

OPK | TA

Overview

Corporate Details

ISIN(s):
US68375N1037
LEI:
Country:
Israel
Address:
4400 Biscayne Blvd., 33137 Miami
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a diversified and fully-integrated healthcare company operating in the diagnostics and pharmaceuticals sectors. Its diagnostics division features BioReference Laboratories, one of the largest full-service clinical reference laboratories in the U.S. The pharmaceuticals division focuses on discovering, developing, and commercializing novel therapies for serious diseases. Key marketed products include NGENLA™, a next-generation human growth hormone therapy for pediatric patients, and RAYALDEE®. The company's research pipeline is centered on advancing multispecific therapies for conditions like cancer and infectious diseases, supported by strategic partnerships with leading pharmaceutical and scientific organizations such as Pfizer and Merck.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for OPKO Health Inc.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 01:46
Director's Dealing
Immediate Report
English 51.4 KB
2025-08-20 01:46
Foreign Filer Report
Immediate Report
English 36.3 KB
2025-08-10 02:28
Director's Dealing
Immediate Report
English 51.5 KB
2025-08-10 02:28
Related Party Transaction
Immediate Report
English 36.3 KB
2025-08-01 01:34
Foreign Filer Report
Report of Periodic or Interim Report
English 36.6 KB
2025-08-01 01:19
Quarterly Report
Immediate Report
English 202.1 KB
2025-08-01 01:19
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-08-01 01:13
Earnings Release
Immediate Report
English 292.7 KB
2025-08-01 01:13
Foreign Filer Report
Immediate Report
English 36.4 KB
2025-07-26 22:17
Report Publication Announcement
Immediate Report
English 162.7 KB
2025-07-26 22:17
Report Publication Announcement
Immediate Report
English 36.4 KB
2025-07-08 17:09
Regulatory News Service
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
English 160.7 KB
2025-07-08 17:09
Foreign Filer Report
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
English 36.4 KB
2025-06-25 18:02
Report Publication Announcement
to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
English 118.5 KB
2025-06-25 18:02
Regulatory News Service
to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
English 36.4 KB

Automate Your Workflow. Get a real-time feed of all OPKO Health Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OPKO Health Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK